rs138156467
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 18P and 1B. PVS1PM2PP5_Very_StrongBS1_Supporting
The NM_000760.4(CSF3R):c.1640G>A(p.Trp547Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.000461 in 1,613,276 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00048 ( 1 hom. )
Consequence
CSF3R
NM_000760.4 stop_gained
NM_000760.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 4.77
Genes affected
CSF3R (HGNC:2439): (colony stimulating factor 3 receptor) The protein encoded by this gene is the receptor for colony stimulating factor 3, a cytokine that controls the production, differentiation, and function of granulocytes. The encoded protein, which is a member of the family of cytokine receptors, may also function in some cell surface adhesion or recognition processes. Alternatively spliced transcript variants have been described. Mutations in this gene are a cause of Kostmann syndrome, also known as severe congenital neutropenia. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 17 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-36468158-C-T is Pathogenic according to our data. Variant chr1-36468158-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 570920.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00048 (701/1460948) while in subpopulation NFE AF= 0.000608 (676/1111494). AF 95% confidence interval is 0.00057. There are 1 homozygotes in gnomad4_exome. There are 324 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF3R | NM_000760.4 | c.1640G>A | p.Trp547Ter | stop_gained | 13/17 | ENST00000373106.6 | NP_000751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF3R | ENST00000373106.6 | c.1640G>A | p.Trp547Ter | stop_gained | 13/17 | 1 | NM_000760.4 | ENSP00000362198 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152210Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
42
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000256 AC: 64AN: 250056Hom.: 0 AF XY: 0.000244 AC XY: 33AN XY: 135066
GnomAD3 exomes
AF:
AC:
64
AN:
250056
Hom.:
AF XY:
AC XY:
33
AN XY:
135066
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000480 AC: 701AN: 1460948Hom.: 1 Cov.: 32 AF XY: 0.000446 AC XY: 324AN XY: 726754
GnomAD4 exome
AF:
AC:
701
AN:
1460948
Hom.:
Cov.:
32
AF XY:
AC XY:
324
AN XY:
726754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000276 AC: 42AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74492
GnomAD4 genome
AF:
AC:
42
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
18
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
29
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | This sequence change creates a premature translational stop signal (p.Trp547*) in the CSF3R gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CSF3R are known to be pathogenic (PMID: 24753537, 26324699). This variant is present in population databases (rs138156467, gnomAD 0.05%). This premature translational stop signal has been observed in individual(s) with autosomal recessive congenital neutropenia (PMID: 26324699). ClinVar contains an entry for this variant (Variation ID: 570920). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 05, 2016 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2023 | Identified in the heterozygous state in the published literature in patients with myelodysplasic syndrome, but additional clinical information was not provided (Trottier et al., 2019; Trottier et al., 2020; Feurstein et al., 2021); Published functional studies demonstrate loss of function of the gene product (Trottier et al., 2020); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32499645, 32888494, 33108454, 35178734, 31345219, 34778134, 33510405, 32966608, 26324699) - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 12, 2021 | DNA sequence analysis of the CSF3R gene demonstrated a sequence change, c.1640G>A, which results in the creation of a premature stop codon at amino acid position 547, p.Trp547*. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated CSF3R protein with potentially abnormal function. This sequence change was identified in a compound heterozygous state with a second splice site pathogenic variant in a patient with congenital neutropenia (CN) (PMID: 26324699). Loss-of-function variants in CSF3R have been reported in patients with neutropenia (PMID: 24753537, 26324699). - |
CSF3R-Related Disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 02, 2024 | Variant summary: CSF3R c.1640G>A (p.Trp547X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00026 in 250056 control chromosomes. c.1640G>A has been reported in the literature in at least one compound heterozygous individuals affected with congenital neutropenia (e.g. Klimiankou_2015). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 26324699). ClinVar contains an entry for this variant (Variation ID: 570920). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Inherited Immunodeficiency Diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2019 | - - |
Hereditary neutrophilia;C4310764:Autosomal recessive severe congenital neutropenia due to CSF3R deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 21, 2022 | - - |
CSF3R-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 17, 2024 | The CSF3R c.1640G>A variant is predicted to result in premature protein termination (p.Trp547*). This variant has been reported in the compound heterozygous state in a patient with congenital neutropenia (Klimiankou et al. 2015. PubMed ID: 26324699) and also in a patient with history of bladder cancer who developed therapy-related myelodysplastic syndrome (Trottier et al. 2019., https://doi.org/10.1182/blood-2019-129492). This variant is reported in 0.051% of alleles in individuals of European (non-Finnish) descent in gnomAD. Nonsense variants in CSF3R are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A;A;A;A;A;A;A
Vest4
ClinPred
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at